Critical Medicines Act aims to reduce Europe's reliance on Asian suppliers for pharmaceuticals.
ℹ️ Browser-based reading · AI studio voice coming soon
The European Union has reached agreement on the Critical Medicines Act, a plan designed to reduce Europe's dependence on China and India for essential medicines and pharmaceutical ingredients, according to EurActiv.
The measure addresses supply chain vulnerabilities exposed during recent global health disruptions. By strengthening domestic and allied pharmaceutical production capacity, the EU aims to ensure reliable access to critical medicines during future crises. The agreement represents a strategic shift toward supply chain resilience and reduced geopolitical exposure in healthcare.